10.1016/j.freeradbiomed.2014.09.033 Free Radic
Summary Semaglutide will not appear as a named entry on routine blood panels, and tracking dozens of people over three months showed that observed lab shifts reflected biological responses, not direct detection of the drug
Studies show that it works far better than laxatives and lifestyle changes alone for these patients
Like any medication, GLP-1s can cause side effects, especially in the early stages of treatment
Its a field thats already undergoing a revolution, with millions of people across the US now using semaglutide and tirzepatide, sold as Wegovy and Zepbound for weight loss (and for diabetes as the better-known Ozempic and Mounjaro)
As I started to explore which telehealth platforms I might consider, many advertised that they followed the strict FDA guidelines for BMI and I knew that I wouldn't qualify and quickly became discouraged